LianBio
LIANYDrugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Mavacamten | Phase 3 | Obstructive Hypertrophic Cardiomyopathy | - | - |
Lotilaner | Phase 3 | Blepharitis | - | - |
Frequently asked questions
What is in LianBio's drug pipeline?→
CatalystAlert tracks 2 drug candidates in LianBio's (LIANY) pipeline across Phase 3. Its lead program is Mavacamten (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is LianBio's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for LianBio (LIANY) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LIANY biotech catalysts?→
Add LIANY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow LianBio's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.